Thomas Fredrick
Impact in
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
Papers in
-
- Retinal Development and Disorders 2
- Peroxisome Proliferator-Activated Receptors 1
- Angiogenesis and VEGF in Cancer 1
- Ubiquitin and proteasome pathways 1
-
- Retinal Diseases and Treatments 2
- Co-authors
- Yan Gong (7 shared papers)Chi‐Hsiu Liu (6 shared papers)Nicholas Saba (6 shared papers)Peyton Morss (6 shared papers)Jing Chen (5 shared papers)Ye Sun (5 shared papers)Lois E. H. Smith (6 shared papers)Lucy Evans (3 shared papers)
- Journals
- Clinical Gastroenterology and Hepatology (1 paper)The Journal of Experimental Medicine (1 paper)BMC Biology (1 paper)PLoS ONE (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)
- Partner nations
- United StatesChinaSweden
In The Last Decade
Thomas Fredrick
13 papers receiving 474 citations
Peers
Comparison fields: 5 of 54
- Ophthalmology 197
- Neurology 40
- Radiology, Nuclear Medicine and Imaging 100
- Cancer Research 59
- Biochemistry 28
Countries citing papers authored by Thomas Fredrick
This map shows the geographic impact of Thomas Fredrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Fredrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Fredrick more than expected).
Fields of papers citing papers by Thomas Fredrick
This network shows the impact of papers produced by Thomas Fredrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Fredrick. The network helps show where Thomas Fredrick may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Fredrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 89 | |
| 2 | 2015 | 83 | |
| 3 | 2017 | 67 | |
| 4 | 2017 | 55 | |
| 5 | 2017 | 43 | |
| 6 | 2016 | 40 | |
| 7 | 2015 | 39 | |
| 8 | 2016 | 29 | |
| 9 | 2022 | 24 | |
| 10 | 2022 | 6 | |
| 11 | 2025 | 1 | |
| 12 | 2021 | 1 | |
| 13 | 2021 | 1 | |
| 14 | 2025 | 0 | |
| 15 | 2025 | 0 |
About Thomas Fredrick
Thomas Fredrick is a scholar working on Molecular Biology, Ophthalmology, Epidemiology, Neurology and Genetics, having authored 15 papers that have together received 478 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (2 papers), Retinal Development and Disorders (2 papers), Microscopic Colitis (2 papers), Inflammatory Bowel Disease (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Ophthalmology (197 citations), Neurology (40 citations), Radiology, Nuclear Medicine and Imaging (100 citations), Cancer Research (59 citations) and Biochemistry (28 citations). Thomas Fredrick has collaborated with scholars based in United States, China and Sweden. Frequent co-authors include Yan Gong, Chi‐Hsiu Liu, Nicholas Saba, Peyton Morss, Jing Chen, Ye Sun, Lois E. H. Smith, Lucy Evans, Katherine Tian and Zhongjie Fu. Their work appears in journals such as Clinical Gastroenterology and Hepatology, The Journal of Experimental Medicine, BMC Biology, PLoS ONE and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.